Larimar Therapeutics
$3.59
35
+$0.12+3.46% Today
Statistics
Day High
3.64
Day Low
3.48
52W High
6.42
52W Low
2.22
Volume
1,657,692
Avg. Volume
1,738,685
Mkt Cap
307.27M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-0.39592
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-161.21MNet Income
Analyst Ratings
11.67Average Price Target
The highest estimate is 14.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LRMR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sarepta Therapeutics
SRPT
Mkt Cap1.62B
PTC Therapeutics
PTCT
Mkt Cap5.88B
Solid Biosciences
SLDB
Mkt Cap659.61M
Biomarin Pharmaceutical
BMRN
Mkt Cap10.81B
Ultragenyx Pharmaceutical
RARE
Mkt Cap2.16B
CRISPR Therapeutics
CRSP
Mkt Cap4.9B
Editas Medicine
EDIT
Mkt Cap383.65M
Intellia Therapeutics
NTLA
Mkt Cap1.69B
uniQure N.V.
QURE
Mkt Cap1.74B
About
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
Show more...
CEO
Dr. Carole S. Ben-Maimon M.D.
Employees
65
Country
United States
ISIN
US5171251003
Listings
0 Comments
Share your thoughts
FAQ
What is Larimar Therapeutics stock price today?▼
The current price of LRMR is $3.59 USD — it has increased by +3.46% in the past 24 hours. Watch Larimar Therapeutics stock price performance more closely on the chart.
What is Larimar Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Larimar Therapeutics stocks are traded under the ticker LRMR.
Is Larimar Therapeutics stock price growing?▼
LRMR stock has risen by +15.81% compared to the previous week, the month change is a +0.28% rise, over the last year Larimar Therapeutics has showed a +24.65% increase.
What is Larimar Therapeutics market cap?▼
Today Larimar Therapeutics has the market capitalization of 307.27M
When is the next Larimar Therapeutics earnings date?▼
Larimar Therapeutics is going to release the next earnings report on August 06, 2026.
What were Larimar Therapeutics earnings last quarter?▼
LRMR earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.53 USD resulting in a +42.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Larimar Therapeutics revenue for the last year?▼
Larimar Therapeutics revenue for the last year amounts to 0 USD.
What is Larimar Therapeutics net income for the last year?▼
LRMR net income for the last year is -161.21M USD.
How many employees does Larimar Therapeutics have?▼
As of June 15, 2026, the company has 65 employees.
In which sector is Larimar Therapeutics located?▼
Larimar Therapeutics operates in the Health & Wellness sector.
When did Larimar Therapeutics complete a stock split?▼
The last stock split for Larimar Therapeutics was on May 29, 2020 with a ratio of 1:12.
Where is Larimar Therapeutics headquartered?▼
Larimar Therapeutics is headquartered in Bala Cynwyd, United States.